Transduced human PEP-1-catalase fusion protein attenuates ischemic neuronal damage

Dae Won Kim1, Hoon Jae Jeong, Hye Won Kang

  • 1Department of Biomedical Science and Research Institute for Bioscience and Biotechnology, College of Medicine, Hallym University, Chunchon 200-702, Korea.

Insights

PEP-1-CAT and PEP-1-SOD fusion proteins protect neuronal cells from oxidative stress. These cell-permeative enzymes show potential as therapeutic agents for diseases linked to reactive oxygen species (ROS), including stroke.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Molecular Biology

Background:

  • Reactive oxygen species (ROS) contribute to diseases through oxidative stress.
  • Antioxidant enzymes like Catalase (CAT) and Superoxide Dismutase (SOD) combat ROS.
  • Ischemia involves oxidative stress and altered antioxidant defenses.

Purpose of the Study:

  • To investigate the protective effects of Catalase (CAT) using cell-permeative expression vectors.
  • To evaluate the therapeutic potential of fusion proteins in oxidative stress-related conditions.

Main Methods:

  • Construction of PEP-1-CAT cell-permeative expression vectors.
  • Treatment of neuronal cells with PEP-1-CAT fusion proteins.
  • Immunohistochemical analysis of hippocampal neuronal death following transient forebrain ischemia.
  • Evaluation of PEP-1-SOD fusion protein effects.

Main Results:

  • PEP-1-CAT fusion proteins rapidly entered neuronal cells.
  • PEP-1-CAT protected neuronal cells against oxidative stress-induced death.
  • PEP-1-CAT prevented neuronal cell death in the hippocampus after ischemia.
  • PEP-1-SOD also demonstrated protective effects.

Conclusions:

  • Transduced PEP-1-CAT and PEP-1-SOD fusion proteins offer protection against oxidative stress.
  • These fusion proteins show promise as therapeutic agents for ROS-mediated diseases.
  • Potential applications include stroke and other oxidative stress-related human diseases.

Related Concept Videos